Europe
.jpg/r%5Bwidth%5D=1280&r%5Bheight%5D=720/66d43720-a517-11f0-9ed1-0b88c9b24259-Untitled%20design%20(9).webp)
7 January 2026 As he hands over the baton, Bobby Mukherjee reflects on his time leading the Chartered Institute of Patent Attorneys—from progressing the soon-to-be-launched paid apprenticeship schemes to engaging with the UK body’s in-house members. Sarah Speight reports.
31 December 2025
30 December 2025
29 December 2025
23 December 2025
Latest Features
Europe
A number of ongoing legislative processes are likely to significantly impact the life sciences industry this year, writes Jackie Mulryne of Morgan Lewis.
Europe
The High Court’s ruling clarifies aspects of the SPC waiver but leaves unresolved questions relating to export-country rights and confidentiality, say Claire Phipps-Jones and Luke Norton of Bristows.
Europe
As Big Pharma stalls investment in the UK, the government urgently needs to return to the negotiating table to salvage a key growth area, writes Tim Belcher of EIP.
Europe
In its first year, uptake of cases at the Unified Patent Court has surpassed most expectations. Darren Smyth of EIP delves into the facts and figures behind the headlines, with some surprising results.
Europe
It remains to be seen whether AI developers in the medical sector will benefit from the UK’s ‘flexible’ regulatory environment or find the lack of cohesion detrimental, say Jackie Mulryne and Beatriz San Martin of Arnold & Porter.
Europe
Is the court’s public access rule unfit for purpose? Lawyers at Mathys & Squire are arguing for pleadings and evidence to be automatically made available on request, finds Muireann Bolger.
Biotechnology
Recent clashes over patents covering modified guide RNAs have exposed different approaches from the US and Europe—and new complications for the field, says Claire Irvine of HGF.
Big Pharma
Despite a rocky start, with case-management issues and plenty of scepticism from stakeholders, there is much to applaud in the UPC’s first four months, write Sebastian Moore and John Lao of Herbert Smith Freehills.
More News
19 December 2025 With its landmark ruling, the court has delivered guidance for patentees and litigants— including three takeaways for counsel and rights holders, explain Tobias Wuttke and Axel Berger of Bardehle Pagenberg.
18 December 2025 A UK appellate court has revived a key patent for the tech, finding flaws in the lower court’s handling of the case and obviousness analysis over prior art.
16 December 2025 UK court hears claims that a delay and construction inconsistency led to the alleged wrongful invalidation of a patent at the heart of a global dispute.
15 December 2025 The proposed 1,400-strong firm will combine Taylor Wessing's top UK and European practice with Winston & Strawn's US-focused IP litigation team.
15 December 2025 The country aims to become the world’s third-largest life sciences economy by 2035, but stalled investments, regulatory hurdles, and talent shortages are raising questions about whether the target is achievable, finds Marisa Woutersen.
11 December 2025 The lateral hire from Covington & Burling will strengthen the firm's cross-border expertise as the UK and EU markets ‘navigate regulatory and technological shifts’, said the firm.
8 December 2025 The firm has added a disputes specialist with experience in pharma, biotech and manufacturing sectors across multiple jurisdictions.
Get up-to-date information on all our publications and events
Get critical life sciences news direct to your inbox